Regal Investment Advisors »

Intra Cellular Therapies shares owned by Regal Investment Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Regal Investment Advisors from 13F filings

Historical chart of Regal Investment Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Regal Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Regal Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $709k 14k 52.09
2023-06-30 $850k 13k 63.32
2023-03-31 $522k 9.6k 54.15

More positions owned by Regal Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Call Call Option (QQQ)
Apple (AAPL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Microsoft Corporation (MSFT)
Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Abbvie (ABBV)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Procter & Gamble Company (PG)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Pfd And Incm Sec (PFF)
Johnson & Johnson (JNJ)

View all positions for Regal Investment Advisors

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Alliancebernstein
Franklin Resources
Wellington Management Company
Jpmorgan Chase & Co
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management

View all funds holding Intra Cellular Therapies